UBS Group’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
II
BFS
OFS
CIA
PFG
UBS Group's IBD Position: Q4 2025 in Review
UBS Group sold out of Inspire Corporate Bond ETF (IBD) in Q4 2025, closing a stake of 155 shares — an estimated $3.74K sold.
UBS Group first reported a position in IBD in Q4 2017 and held it in 13 quarters. The position peaked at $71K in Q3 2022. 99 funds tracked by Wall St. Rank hold IBD as of Q4 2025.
- UBS Group reported no remaining Inspire Corporate Bond ETF position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 155 Inspire Corporate Bond ETF shares in Q4 2025, an estimated $3.74K.
- UBS Group first reported a position in Inspire Corporate Bond ETF in Q4 2017 and held it in 13 quarters.
- UBS Group's Inspire Corporate Bond ETF position peaked at $71K in Q3 2022.
- 99 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.